Health Care

The Department of Veterans Affairs continues to retaliate against whistleblowers despite repeated pledges to stop punishing those who speak up, a national group said Tuesday.

An Iowa company has been awarded the first license by the U.S. Department of Agriculture to develop a bird flu vaccine.

A British pharmaceutical company that told Arkansas not to use its products during executions is trying to determine if the state plans to use them anyway, but prison officials are dismissing inquiries about the drug by citing a new law that makes all execution policies an official state secret.

Universal Health Services, one of the largest hospital operators in the U.S., said Friday it will buy addiction treatment facility company Foundations Recovery Network for $350 million.

Perrigo urged shareholders to reject Mylan's $27 billion hostile takeover offer, saying it undervalues the company.

Shares of Mylan are up 2 percent before the opening bell after the pharmaceutical company went ahead with its hostile, $27.14 billion bid for Perrigo.

Shares of Gilead Sciences rose Thursday after the hepatitis C drugmaker said it will issue $10 billion in debt, leading to speculation that it may be getting ready to make a big acquisition.

A closely watched study of GlaxoSmithKline's Breo Ellipta respiratory treatment failed to prove that it extends patients' lives, denying the drugmaker a much-needed marketing edge in one of its key medicine categories.

Horizon Pharma is continuing its hostile takeover bid for Depomed by offering to exchange a portion of its stock for shares of the rival drugmaker.

Medtronic Inc. (MDT) on Thursday reported fiscal first-quarter profit of $820 million.

Canadian drugmaker Valeant will work with British competitor AstraZeneca on a potential treatment for psoriasis a few months after biotech giant Amgen said it was ending research on the drug because of a link to suicidal thoughts and behavior.

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Chevron Corp., up 56 cents to $80.99 Oil stocks tracked the price of crude, which shook off early losses and rallied on a report of a June drop in U.S. production.

Mylan NV's shareholders approved the proposed buyout of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon.